Central glucagon-like peptide 1 receptor activation inhibits Toll-like receptor agonist-induced...
GLP-1R agonists may reduce cardiometabolic complications in part through reduction of inflammation. Here we show, using pharmacology and genetics, that the anti-inflammatory actions of GLP-1RAs to...
cell.com